Siemens Healthineers and MicroPort Forge Strategic Partnership to Co-Develop Domestic Angiography Systems for the Chinese Market

Shanghai, June 24, 2020 /PRNewswire/ -- Siemens Healthineers and MicroPort Group have reached a strategic partnership in Shanghai. The two parties will jointly develop and manufacture domestically produced angiography systems, effectively combining and leveraging their respective advantages, integrating resources, and optimizing allocation to enhance technological innovation capabilities and better meet the diverse needs of customers in the Chinese market.

Interventional therapy has now become the third major clinical treatment modality, alongside internal medicine and surgical treatments. Characterized by minimal invasiveness and reduced patient discomfort, it overcomes the limitations of pharmacological interventions and surgical procedures, thereby achieving rapid development in the modern healthcare landscape. Continuous innovation in imaging equipment, interventional devices, and consumables serves as a key driver behind the robust growth of interventional therapy. As industry leaders deeply entrenched in imaging equipment and interventional devices, Siemens Healthineers and MicroPort will leverage this collaboration to integrate their respective advantageous resources in their specialized fields. This partnership aims to respond to national policy initiatives and meet the diverse market demands in China.

Peng Bo, Chairman of the Executive Committee of MicroPort Greater China and Chief Marketing Officer, stated: “Siemens Healthineers is a global leader in the supply of medical imaging equipment. Through this collaboration, MicroPort’s clinical resources in the cardiovascular field complement Siemens Healthineers’ technological expertise in imaging equipment, enabling both parties to optimize and integrate their channel and service resources, thereby providing high-quality, accessible healthcare solutions to more patients in China.”

Leveraging over a century of accumulated expertise in the imaging field, Siemens Healthineers’ angiography systems continuously innovate to deliver higher imaging precision, lower radiation doses, more convenient and flexible gantry movement, and more comprehensive clinical applications. These patient- and physician-centric breakthrough products and solutions consistently support the advancement of interventional therapy. As an innovation leader in the angiography system sector, Siemens Healthineers promotes multidisciplinary integration while practicing precision medicine, thereby facilitating the expansion of interventional therapy into broader fields.

“Siemens Healthineers’ Clinical Therapy business is committed to meeting the diverse needs of the Chinese market for high-quality medical devices in clinical settings, and actively promoting the development of interventional medicine in China. This strategic collaboration with MicroPort will further deepen the localization of Siemens Healthineers’ angiography systems in China,” said Pu Zhengrong, Vice President of Clinical Therapy Systems at Siemens Healthineers Greater China.

About Siemens Healthineers

Siemens Healthineers (Frankfurt Stock Exchange ticker: SHL) is shaping the future of the healthcare industry. Headquartered in Erlangen, Germany, Siemens Healthineers is a leading medical technology company committed to supporting global healthcare providers through its regional entities in advancing precision medicine, transforming diagnostic and therapeutic models, enhancing patient experience, and realizing digital healthcare, thereby comprehensively helping them increase value. Siemens Healthineers continuously develops its portfolio of products and services, including AI-based applications and digital solutions that play an increasingly important role in the development of next-generation medical technologies. These new applications will further strengthen the company’s foundation in the fields of in vitro diagnostics, image-guided therapy, and in vivo diagnostics. Meanwhile, Siemens Healthineers provides complementary services and solutions to help healthcare providers enhance their capacity to deliver high-quality and efficient care to patients. In fiscal year 2019 (ended September 30, 2019), Siemens Healthineers reported total revenue of €14.5 billion and adjusted profit of €2.5 billion, with approximately 52,000 employees worldwide.

For more information, please visit the official website of Siemens Healthineers:https://www.healthcare.siemens.com.cn

About MicroPort:

MicroPort® originated from Shanghai MicroPort Medical (Group) Co., Ltd., established in 1998. Headquartered in Zhangjiang Science City, Shanghai, China, it is a leading innovative high-end medical device group whose products have entered more than 10,000 hospitals worldwide. With nearly 7,000 employees, on average one MicroPort® product is used every six seconds. MicroPort® is committed to providing inclusive, true, good, and beautiful solutions that extend and reshape lives.